Tag: Pipeline embolisation device

in silico clinical trials

BRAIN 2021: In silico clinical trials likely to play complementary role...

In silico studies involving virtual participants hold great potential in the neurovascular field—and the broader medical industry—with their future role in the generation of...

“Welcome and exciting”: Evidence mounts in favour of flow diversion technologies

Multiple pieces of clinical research supporting the use of flow diverter devices to treat intracranial aneurysms have come to light so far in 2021....
fred flow diverter

FRED flow diverter safe and effective in treatment of “appropriately selected”...

The Flow Redirection Endoluminal Device stent system (FRED; MicroVention)—a flow diverter used to treat intracranial aneurysms—has been deemed safe and effective for this indication,...

Data from 1,000 aneurysms indicate Pipeline Embolization Device is safe and...

The endovascular treatment of intracranial aneurysms using the Pipeline Embolization Device (PED; Medtronic) has been deemed safe and effective following a study involving data...

Radiation reduced with flow diversion for treatment of internal carotid artery...

According to new research, treatment of large and giant proximal internal carotid artery aneurysms using the Pipeline embolisation device (Covidien/Medtronic) requires less radiation, less...